Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,291 papers from all fields of science
Search
Sign In
Create Free Account
Recombinant interferon beta-1a
Known as:
INTERFERON BETA-1A,RECOMBINANT
, Interferon Beta-1A
A synthetic version of naturally occurring interferons that have immunomodulatory, antiviral and antiproliferative activities. It may exert antitumor…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
38 relations
Acquired Immunodeficiency Syndrome
Age related macular degeneration
Autoimmune Diseases
Brain Neoplasms
Expand
Narrower (1)
Rebif
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
High-dose, high-frequency recombinant interferon beta-1a in the treatment of multiple sclerosis.
H. Hartung
Expert Opinion on Pharmacotherapy
2009
Corpus ID: 30814153
BACKGROUND There is at present no cure for multiple sclerosis (MS), and existing therapies are designed primarily to prevent…
Expand
Review
2009
Review
2009
High-dose, high-frequency recombinant interferon beta-1a in the treatment of multiple sclerosis
H. Hartung
2009
Corpus ID: 73029250
Background: There is at present no cure for multiple sclerosis (MS), and existing therapies are designed primarily to prevent…
Expand
2009
2009
AGE-RELATED CHANGES IN MOTOR SUBTLE SIGNS AMONG GIRLS AND BOYS WITH ADHD
A. Poulton
,
R. Nanan
Neurology
2009
Corpus ID: 207115784
Fenstermacher JD. In normal rat, intraventricularly administered insulin-like growth factor-1 is rapidly cleared from CSF with…
Expand
1995
1995
A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients…
L. Jacobs
,
D. Cookfair
,
+7 authors
J. Simon
Multiple Sclerosis
1995
Corpus ID: 30064140
The design and conduct of a randomized, double-blinded, placebo-controlled, multicenter, phase III study of recombinant…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE